Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Asia Cervical Cancer Screening Market, Size, Forecast 2024-2032, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... billion by 2032 up from US$ 3.76 billion in 2023. This expected growth is going to be a CAGR 4.23% between 2024 and 2032. Women health and preventive medicine has been of most concern resulting ... Read More
-
Patient Derived Xenograft / PDX Models
... the year 2023, is expected to reach US$510.8 Million by 2030, growing at a CAGR of 16.3% over the analysis period 2023-2030. Pre-Clinical Drug Development Application, one of the segments analyzed in the report, is ... Read More
-
Cancer Stem Cells
... by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.3 ... Read More
-
Breast Cancer Liquid Biopsy
... reach US$1.1 Billion by 2030, growing at a CAGR of 21.4% over the analysis period 2023-2030. Reagent Kits, one of the segments analyzed in the report, is expected to record a 22.0% CAGR and reach ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing
... is expected to reach US$4.0 Billion by 2030, growing at a CAGR of 13.7% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 13.1% ... Read More
-
Genomics in Cancer Care
... reach US$62.1 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Instruments, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$25.0 ... Read More
-
Colposcopy
... of 4.0% over the analysis period 2023-2030. Cervical Cancer Screening Application, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$440.5 Million by the end of the ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More
-
Gynecological Cancer Drugs
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Cervical Cancer Drugs, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$10.3 Billion ... Read More
-
Intraoperative Radiation Therapy
... at a CAGR of 5.8% over the analysis period 2023-2030. Systems / Accelerators, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$22.9 Million by the end ... Read More
-
Oncology Information Systems
... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.5 Billion by ... Read More
-
Antineoplastic Agents
... at a CAGR of 7.1% over the analysis period 2023-2030. Chemotherapeutic Agents Application, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$137.9 Billion by the end ... Read More
-
Immunohistochemistry (IHC) - Market Insights, Competitive Landscape, and Market Forecast- 2030
... Research Institutes, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the growing instances of infectious diseases and ... Read More
-
Sunitinib Malate
... CAGR of 9.7% over the analysis period 2023-2030. Above 99% Purity Sunitinib Malate, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$109.0 Million by the end ... Read More
-
Liver Cancer Diagnostics
... at a CAGR of 7.3% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.8 Billion by the end of ... Read More
-
Non-Hodgkin Lymphoma Therapeutics
... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$10.1 Billion by the ... Read More
-
Non-Melanoma Skin Cancer
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Basal Cell Carcinoma (BCC), one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$835.6 ... Read More
-
NDDS in Cancer Therapy
... reach US$73.2 Billion by 2030, growing at a CAGR of 20.8% over the analysis period 2023-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 20.7% CAGR and reach US$67.8 ... Read More
-
Cancer Immunotherapy
... at a CAGR of 13.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$266.2 Billion by the end of ... Read More
-
Cancer Biomarkers
... at a CAGR of 16.8% over the analysis period 2023-2030. Protein Biomarkers, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$42.9 Billion by the end of ... Read More
-
Immunomodulators
... 5.7% over the analysis period 2023-2030. Immunosuppressants, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$209.8 Million by the end of the analysis period. Growth in ... Read More
-
Cancer Registry Software
... by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Standalone Software, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$116.6 Million by ... Read More
-
Head and Neck Cancer Therapeutics
... is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. PD Inhibitors, one of the segments analyzed in the report, is expected to record a 8.4% ... Read More
-
Cervical Cancer Treatment
... at a CAGR of 5.9% over the analysis period 2023-2030. Squamous Cell Carcinoma (SCC) Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$9.1 Billion by ... Read More
-
Global Lung Cancer Therapy Market: Analysis By Treatment Method (Non-Invasive and Minimally Invasive), By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, and Other Therapies), By Indication (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Carcinoid), By End-User (Hospitals, Oncology Clinics, Research Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... Cancer (SCLC), Carcinoid), By End-User (Hospitals, Oncology Clinics, Research Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 ... Read More
Research Assistance
